RENEE KELLING: Open Payments
NPI 1316952104 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 5 payments from 5 companies in 2025. Trend: 2023 $1,217 · 2024 $810 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $97 |
| Novo Nordisk Inc | 1 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $91 |
| Janssen Pharmaceuticals, Inc | 1 | $88 |
Products named: FASENRA, Wegovy, SPRAVATO.
Industry payments across MD — which companies pay providers there.
